Inhaled triple therapy in chronic obstructive pulmonary disease Reply

被引：1
|
作者：
Papi, Alberto [1 ]
Singh, Dave [2 ]
Petruzzelli, Stefano [3 ]
Guasconi, Alessandro [3 ]
Vestbo, Jorgen [2 ]
机构：
[1] Univ Ferrara, Resp Med, I-44121 Ferrara, Italy
[2] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England
[3] Chiesi Farmaceut SpA, Global Clin Dev, Parma, Italy
来源：
LANCET | 2018年 / 392卷 / 10153期
关键词：
D O I：
10.1016/S0140-6736(18)31778-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1113 / 1114
页数：2
相关论文
共 50 条
  • [21] Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
    Ferguson, Gary T.
    Shaikh, Asif
    Tetzlaff, Kay
    Mueller, Achim
    Magnussen, Helgo
    Watz, Henrik
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2879 - 2888
  • [22] Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web Reply
    Harries, Anthony D.
    Ade, Serge
    Nguyen Binh Hoa
    Satyanarayana, Srinath
    Kumar, Ajay
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (12) : 1318 - 1318
  • [23] Inhaled corticosteroids and chronic obstructive pulmonary disease
    Sapey, E
    Langford, NJ
    Kendall, MJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2000, 25 (04) : 235 - 238
  • [24] Inhaled corticosteroids for chronic obstructive pulmonary disease
    Cazzola, Mario
    Rogliani, Paola
    Novelli, Lucia
    Matera, Maria Gabriella
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2489 - 2499
  • [25] Inhaled Anticholinergics for Chronic Obstructive Pulmonary Disease
    Singh, Sonal
    Furberg, Curt D.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (10) : 920 - 922
  • [26] Inhaled corticosteroids for chronic obstructive pulmonary disease
    Park, Hye Yun
    Man, S. F. Paul
    Sin, Don D.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [27] High or low impact? Triple therapy in chronic obstructive pulmonary disease
    McDonald, Christine F.
    Bardin, Philip G.
    RESPIROLOGY, 2018, 23 (10) : 891 - 892
  • [28] COST-EFFECTIVENESS OF ROFLUMILAST AS ADD-ON TO TRIPLE INHALED THERAPY VERSUS TRIPLE INHALED THERAPY IN PATIENTS WITH SEVERE AND VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH CHRONIC BRONCHITIS IN THE NETHERLANDS
    Miquel-Cases, A.
    Berk, A.
    Nekeman, S.
    Bastiaanse, M.
    Sellink, A. A.
    Ruiz, S.
    VALUE IN HEALTH, 2017, 20 (09) : A645 - A645
  • [29] COST-EFFECTIVENESS OF ROFLUMILAST AS ADD-ON TO TRIPLE INHALED THERAPY VERSUS TRIPLE INHALED THERAPY IN PATIENTS WITH SEVERE AND VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH CHRONIC BRONCHITIS IN THE UK
    Kiff, C.
    Ruiz, S.
    Varol, N.
    Gibson, D.
    Davies, A.
    Purkayastha, D.
    VALUE IN HEALTH, 2017, 20 (05) : A204 - A204
  • [30] Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
    Humenberger, Magdalena
    Horner, Andreas
    Labek, Anna
    Kaiser, Bernhard
    Frechinger, Rupert
    Brock, Constanze
    Lichtenberger, Petra
    Lamprecht, Bernd
    BMC PULMONARY MEDICINE, 2018, 18
12345